Loading clinical trials...

Interaction of Muscle Dystrophy, Glucose Metabolism and Insulin Sensitivity | Clinical Trials | Clareo Health

UNKNOWNNCT05052073

Interaction of Muscle Dystrophy, Glucose Metabolism and Insulin Sensitivity

The aim of this project to characterize systemic and organ-specific (subcutaneous adipose tissue and skeletal muscle) metabolic responses at rest and during standardized, moderate exercise after an or...

Lead sponsor: Charite University, Berlin, Germany•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Michael Boschmann, Dr. med.

CONTACT

+49.30.450.540.241 michael.boschmann@charite.de

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment60

Start dateSep 2009

Last updatedSep 22, 2021

Condition

Various Forms of Skeletal Muscle Dystrophy

Locations shown

Charite University Medicine, ECRC

Berlin

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 22, 2021Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions